These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31800144)

  • 21. Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.
    Kabaria S; Choi DC; Chaudhuri AD; Mouradian MM; Junn E
    FEBS Lett; 2015 Jan; 589(3):319-25. PubMed ID: 25541488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients.
    Kang W; Chen W; Yang Q; Zhang L; Zhang L; Wang X; Dong F; Zhao Y; Chen S; Quinn TJ; Zhang J; Chen S; Liu J
    Sci Rep; 2016 Jun; 6():28143. PubMed ID: 27335051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
    Goldman JG; Andrews H; Amara A; Naito A; Alcalay RN; Shaw LM; Taylor P; Xie T; Tuite P; Henchcliffe C; Hogarth P; Frank S; Saint-Hilaire MH; Frasier M; Arnedo V; Reimer AN; Sutherland M; Swanson-Fischer C; Gwinn K; ; Kang UJ
    Mov Disord; 2018 Feb; 33(2):282-288. PubMed ID: 29205509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
    Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
    Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D
    Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease.
    Parnetti L; Chiasserini D; Persichetti E; Eusebi P; Varghese S; Qureshi MM; Dardis A; Deganuto M; De Carlo C; Castrioto A; Balducci C; Paciotti S; Tambasco N; Bembi B; Bonanni L; Onofrj M; Rossi A; Beccari T; El-Agnaf O; Calabresi P
    Mov Disord; 2014 Jul; 29(8):1019-27. PubMed ID: 24436092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.
    Kang UJ; Boehme AK; Fairfoul G; Shahnawaz M; Ma TC; Hutten SJ; Green A; Soto C
    Mov Disord; 2019 Apr; 34(4):536-544. PubMed ID: 30840785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
    Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
    Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
    Atik A; Stewart T; Zhang J
    Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.
    Shu Y; Qian J; Wang C
    Open Life Sci; 2020; 15(1):647-653. PubMed ID: 33817253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
    Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Pachi I; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2020; 10(2):481-487. PubMed ID: 32176655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease.
    Li H; Yu L; Li M; Chen X; Tian Q; Jiang Y; Li N
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1189. PubMed ID: 32077254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
    Bougea A; Koros C; Stefanis L
    J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.